Comment on: Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, by Onal C et al response

dc.contributor.authorOnal, Cem
dc.contributor.orcID0000-0002-2742-9021en_US
dc.contributor.pubmedID32980383en_US
dc.contributor.researcherIDD-5195-2014en_US
dc.date.accessioned2022-09-14T10:17:16Z
dc.date.available2022-09-14T10:17:16Z
dc.date.issued2021
dc.identifier.endpageE15en_US
dc.identifier.issn0167-8140en_US
dc.identifier.startpageE15en_US
dc.identifier.urihttp://hdl.handle.net/11727/7731
dc.identifier.volume155en_US
dc.identifier.wos000628819400009en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.radonc.2020.09.030en_US
dc.relation.journalRADIOTHERAPY AND ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleComment on: Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, by Onal C et al responseen_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: